Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
In a 16-year analysis of the pharmaceutical industry, Deloitte for the first time found that…
Rising Star: Arsalan Khan, Head of Strategic Marketing at CDMO Axplora, is a chemical and…
Arvinas and Pfizer are the first to cross the FDA finish line with PROteoosis TArgeting…
The union at fast-growing South Korean CDMO Samsung Biologics launched a planned general strike on…
An unexpected missed interim study in ivonecicimab’s high-profile Harmoni-3 study has sent Summit Therapeutics’ stock…
Four years after winning FDA approval for Overity to treat major depressive disorder (MDD), Axum…
Heart drug developer Esperion to go private in potential $1.1 billion acquisition by ArchiMed
By healthadmin
Shortly after paying $75 million up front for Corstasis Therapeutics and its congestive heart failure…
This is a pivotal year for Ionis Pharmaceuticals, a pioneer in RNA therapeutics. After moving…
Fierce Pharma Asia—Sun acquires organic compounds for $11.75 billion. Astellas Xtandy Peak. BeOne’s PD-1xVEGF Bet
By healthadmin
Sun Pharma will acquire Organon for $11.75 billion. Astellas Pharma predicts that sales of Xtandy…
The pharmaceutical sector faces patent cliffs and rising costs. Explore 2026 trends in AI drug discovery, gene therapy, biopharma manufacturing, clinical pipelines, and FDA approvals to drive efficiency and innovation.